Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001062993-25-004811

President and COO sold 59,505 shares at an average $6.98 ($415,540)

  • President and COO acquired 175,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

RUBINSTEIN JULIE · President and COO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-03-04 Grant or award : show line 1 in the form +175,000 647,754 D
2025-03-05 Sale : show line 2 in the form −40,044 $6.98 $279,507 607,710 D
2025-03-05 Sale : show line 3 in the form −19,461 $6.99 $136,032 588,249 D
Open-market sales · 59,505 sh · avg $6.98 · $415,540
Loading xslF345X05/form4.xml…